VIB logo

VIB

Europe, Oost-Vlaanderen, Belgium, Gent

Description

VIB, a Belgium-based life sciences research institute, performs research for pharmaceutical, agricultural, and industrial applications.

Investor Profile

VIB has made 26 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (35%)
  • Series B (23%)
  • Seed (15%)
  • Series Unknown (15%)
  • Series C (8%)
  • Private Equity (4%)

Country Focus

  • Belgium (92%)
  • Denmark (4%)
  • Brazil (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Agriculture
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical
  • Agtech
  • Health Diagnostics
  • Chemical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does VIB frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 8
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 9
AI
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 6
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 7
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 3
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 4
BioGeneration Ventures
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 3
V-Bio Ventures
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 13
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 15
Ackermans & van Haaren
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 3

What are some of recent deals done by VIB?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938
Protealis

Gent, Oost-Vlaanderen, Belgium

Sustainable plant proteins for Europe​

AgricultureAgTechBiotechnology
Series BJan 23, 2024
Amount Raised: $23,886,612
Tanai Therapeutics

Gent, Oost-Vlaanderen, Belgium

Therapeutics for obesity and obesity-related conditions.

Health CareLife ScienceTherapeutics
SeedDec 6, 2023
Dualyx

Ghent, Oost-Vlaanderen, Belgium

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

BiotechnologyHealth CareMedical
Series AMay 15, 2023
Amount Raised: $43,494,004
Muna Therapeutics

Copenhagen, Hovedstaden, Denmark

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

BiopharmaBiotechnologyMedicalPharmaceutical
Series AJul 9, 2021
Amount Raised: $73,000,000
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series BApr 14, 2021
Amount Raised: $21,572,387
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series BApr 1, 2021
Amount Raised: $4,711,425
Animab

Gent, Oost-Vlaanderen, Belgium

Animab is a biotechnology company specializing in proprietary technology that supports livestock health.

Biotechnology
SeedOct 27, 2020
Amount Raised: $4,006,127